Okay, this commentary is just silly. Integrity at Usana Health Sciences is non-existent. At the very least, the executives and board members lie about their credentials. Then we have the information that is never provided to distributors/recruits and investing community. At the worst, this rises to the level of fraud in a public company.

Here are an analyst’s comments:

NEW YORK, August 28 (newratings.com) – Analyst Timothy S Ramey of DA Davidson maintains his “buy” rating on Usana Health Sciences Inc (USNA.NAS). The 12-18 month target price is set to $60.

In a research note published yesterday, the analyst mentions that the mood at the company’s global convention this past week was upbeat. The Minkow controversy does not seem to have impacted Usana Health Sciences’ business or motivation of the company’s employees, who seemed disinterested in the allegations of the convicted felon Barry Minkow, the analyst says. Given the information regarding the sincerity and integrity of the company and its management team, the charges against Usana Health Sciences do not seem realistic, DA Davidson adds.

Tim – Do you really want people to believe that enthusiastic distributors and your lie about integrity is really enough to deem Usana a “buy”? And do you expect anyone to take you seriously after this nonsense?